Literature DB >> 21499185

Characterization of pediatric patients receiving prolonged mechanical ventilation.

Ezequiel Monteverde1, Analía Fernández, Rossana Poterala, Nilda Vidal, Alejandro Siaba Serrate, Pablo Castelani, Lidia Albano, Fernanda Podestá, Julio A Farias.   

Abstract

OBJECTIVE: To describe the characteristics and risk factors of pediatric patients who receive prolonged mechanical ventilation, defined as ventilatory support for >21 days.
DESIGN: Prospective cohort.
SETTING: Four medical-surgical pediatric intensive care units in four university-affiliated hospitals in Argentina. PATIENTS: All consecutive patients from 1 month to 15 yrs old admitted to participating pediatric intensive care units from June 1, 2007, to August 31, 2007, who received mechanical ventilation (invasive or noninvasive) for >12 hrs.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Demographic and physiologic data on admission to the pediatric intensive care units, drugs and events during the study period, and outcomes were prospectively recorded. A total of 256 patients were included. Of these, 23 (9%) required mechanical ventilation for >21 days and were assigned to the prolonged mechanical ventilation group. Patients requiring prolonged mechanical ventilation had higher mortality (43% vs. 21%, p < .05) and longer pediatric intensive care unit stay: 35 days [28-64 days] vs. 10 days [6-14]). There was no difference between the groups in age and gender distribution, reasons for admission, incidence of immunodeficiencies, or Paediatric Index of Mortality 2 score. The only difference at admission was a higher rate of genetic diseases in prolonged mechanical ventilation patients (26% vs. 9%, p < .05). There was a higher incidence of septic shock (87% vs. 34%, p < .01), acute respiratory distress syndrome (43% vs. 20%, p < .01), and ventilator-associated pneumonia (35% vs. 8%, p < .01) and higher utilization of dopamine (78% vs. 42%, p < .01), norepinephrine (61% vs. 15%, p < .01), multiple antibiotics (83% vs. 20%, p < .01), and blood transfusions (52% vs. 14%, p < .01). The proportion of extubation failure was higher in the prolonged mechanical ventilation group with similar rates of unplanned extubations in both groups. Variables remaining significantly associated with prolonged mechanical ventilation after multivariate analysis were treatment with multiple antibiotics, septic shock, ventilator-associated pneumonia, and use of norepinephrine.
CONCLUSIONS: Patients with prolonged mechanical ventilation have more complications and require more pediatric intensive care unit resources. Mortality in these patients duplicates that from those requiring shorter support.

Entities:  

Mesh:

Year:  2011        PMID: 21499185     DOI: 10.1097/PCC.0b013e3182191c0b

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  4 in total

1.  Extubation Failure and Tracheostomy Placement in Children with Acute Neurocritical Illness.

Authors:  Ellen C Cohn; Tammy S Robertson; Stacey A Scott; Andre M Finley; Rong Huang; Darryl K Miles
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

2.  Pediatric Long-Term Endotracheal Intubation and Role for Tracheostomy: Patient and Provider Factors.

Authors:  Kassi Ackerman; Taylor P Saley; Nasir Mushtaq; Timothy Carroll
Journal:  J Pediatr Intensive Care       Date:  2018-11-26

Review 3.  Ventilation Weaning and Extubation Readiness in Children in Pediatric Intensive Care Unit: A Review.

Authors:  Poletto Elisa; Cavagnero Francesca; Pettenazzo Marco; Visentin Davide; Zanatta Laura; Zoppelletto Fabrizio; Pettenazzo Andrea; Daverio Marco; Bonardi Claudia Maria
Journal:  Front Pediatr       Date:  2022-04-01       Impact factor: 3.569

4.  Predictors of Prolonged Mechanical Ventilation in Pediatric Patients After Cardiac Surgery for Congenital Heart Disease.

Authors:  Avisa Tabib; Seyed Ehsan Abrishami; Mohammad Mahdavi; Hojjat Mortezaeian; Ziae Totonchi
Journal:  Res Cardiovasc Med       Date:  2016-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.